Age-related driving mechanisms of retinal diseases and neuroprotection by transcription factor EB-targeted therapy
Open Access
- 3 April 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 20 (2) , 366-377
Abstract
Retinal aging has been recognized as a significant risk factor for various retinal disorders, including diabetic retinopathy, age-related macular degeneration, and glaucoma, following a growing understanding of the molecular underpinnings of their development. This comprehensive review explores the mechanisms of retinal aging and investigates potential neuroprotective approaches, focusing on the activation of transcription factor EB. Recent meta-analyses have demonstrated promising outcomes of transcription factor EB-targeted strategies, such as exercise, calorie restriction, rapamycin, and metformin, in patients and animal models of these common retinal diseases. The review critically assesses the role of transcription factor EB in retinal biology during aging, its neuroprotective effects, and its therapeutic potential for retinal disorders. The impact of transcription factor EB on retinal aging is cell-specific, influencing metabolic reprogramming and energy homeostasis in retinal neurons through the regulation of mitochondrial quality control and nutrient-sensing pathways. In vascular endothelial cells, transcription factor EB controls important processes, including endothelial cell proliferation, endothelial tube formation, and nitric oxide levels, thereby influencing the inner blood-retinal barrier, angiogenesis, and retinal microvasculature. Additionally, transcription factor EB affects vascular smooth muscle cells, inhibiting vascular calcification and atherogenesis. In retinal pigment epithelial cells, transcription factor EB modulates functions such as autophagy, lysosomal dynamics, and clearance of the aging pigment lipofuscin, thereby promoting photoreceptor survival and regulating vascular endothelial growth factor A expression involved in neovascularization. These cell-specific functions of transcription factor EB significantly impact retinal aging mechanisms encompassing proteostasis, neuronal synapse plasticity, energy metabolism, microvasculature, and inflammation, ultimately offering protection against retinal aging and diseases. The review emphasizes transcription factor EB as a potential therapeutic target for retinal diseases. Therefore, it is imperative to obtain well-controlled direct experimental evidence to confirm the efficacy of transcription factor EB modulation in retinal diseases while minimizing its risk of adverse effects.Keywords
This publication has 99 references indexed in Scilit:
- Biomarkers of ageing: Current state‐of‐art, challenges, and opportunitiesMedComm – Future Medicine, 2023
- TFEB is a central regulator of the aging process and age-related diseasesAgeing Research Reviews, 2023
- Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutationActa Neuropathologica, 2023
- FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROPAngiogenesis, 2023
- TFEB attenuates hyperglycemia‐induced retinal capillary endothelial cells injury via autophagy regulationCell Biology International, 2023
- Silica Nanoparticles Trigger Chaperone HSPB8‐Assisted Selective Autophagy via TFEB Activation in HepatocytesSmall, 2022
- Intermittent Fasting Is Associated With a Decreased Risk of Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2022
- Association of Metformin Use With Age-Related Macular DegenerationJAMA Ophthalmology, 2021
- How autophagy can restore proteostasis defects in multiple diseases?Medicinal Research Reviews, 2020
- Age-related changes of the human retinal vessels: Possible involvement of lipid peroxidationAnnals of Anatomy - Anatomischer Anzeiger, 2019